Plasmodium vivax is the most widely distributed human malarial parasite outside sub-Saharan Africa and responsible for 70-80 million clinical cases annually (Mendis et al., 2001) . Despite its major socioeconomical burden, research in P. vivax remains largely neglected due to the lack of a continuous in vitro culture and the low parasitemias associated with natural infections.
Drug resistance is a major factor in the present resurgence of malaria worldwide. Several genes have now been related to drug resistance in Plasmodium falciparum, which causes the most lethal form of human malaria: pfdhfr and pfdhps, where point mutations confer resistance to dihydrofolate reductase inhibitors (Cowman et al., 1988; Peterson et al., 1988) and sulfadoxine (Brooks et al., 1994; Triglia and Cowman, 1994) , respectively; cytochrome b gene in which the point mutation Y268S can be rapidly selected by atovaquone monotherapy (Korsinczky et al., 2000; Srivastava and Vaidya, 1999) ; pfcrt, which contains specific mutations associated with chloroquine resistance (CQR) (Fidock et al., 2000) ; pfmdr1 and pfmdr2 which encode P-glycoproteins from the ABC (ATP binding cassette) transporters family (Foote et al., 1989; Wilson et al., 1989; Zalis et al., 1993) , and some other transporters that may be involved in chloroquine and quinine resistance (Mu et al., 2003) .
Orthologous genes of pfdhfr and pfcrt have been described in P. vivax, namely pvdhfr (Eldin de Pecoulas et al., 1998) , where point mutations are also associated with resistance against dihydrofolate reductase inhibitors, and pvcg10 (Nomura et al., 2001) , which in contrast to pfcrt contains no specific mutations associated with chloroquine resistance (CQR). The purpose of this work was to identify the ortholog of pfmdr1 in P. vivax, to establish its primary structure and to verify whether amino acid substitutions were associated with CQR among isolates from different regions of the world displaying different phenotypes of chloroquine sensitivity.
To identify P. vivax mdr genes, the oligonucleotides 5 0 -ATGA AAAAGGATCAAAGGCAAC-3 0 (forward) and 5 0 -CTACTTAGC CAGCTTGACGTAC-3 0 (reverse) were used in PCR amplifications of P. vivax genomic DNA from 10 different chloroquine sensitive (CQS) and chloroquine resistant (CQR) isolates or strains from differ- , and all CQS), one sample was from El Salvador in Central America (SalI, CQS), one from Papua New Guinea (NGIV, CQS), one from Indonesia (IndoF, CQR), and four from Papua (CL001, CQS; CL004, CQR; CL007, CQS; and CL014, CQR). Thirty-five PCR cycles were performed, each consisting of denaturation for 30 s at 94°C, renaturation for 30 s at 45°C, and elongation for 5 min at 68°C using elongase (Invitrogen). Unique 4.5 kb DNA fragments were amplified from all samples, cloned in pGEM T-easy plasmids (Promega) and sequenced using an ABI-3100 automatic sequencer (Applied Biosystems). Chromatograms and contigs were evaluated and assembled using the Phred-Phrap-Consed program (http://www.phrap.org/). To guarantee the authenticity of these sequences, all sequences were assigned a Phred value above 40. Moreover, polymorphisms were confirmed by sequencing independent amplifications to exclude PCR artifacts. Synteny was examined using the ACT tool (http://www.sanger.ac.uk/Software/ACT/), and comparing a P. vivax contig containing the P. vivax mdr sequences obtained from the P. vivax genome project at TIGR (http://www.tigr. org/tdb/e2k1/pva1/) with the P. falciparum genome as annotated in PlasmoDB (http://plasmodb.org/). GenBank Accession Nos: CL001 AY571975, CL004 AY571976, CL007 AY571977, CL014 AY571978, IndoF_H4 AY571979, NGIV_H7 AY571980, RO14 AY571981, RO19 AY571982, ROB2 AY571983, and SalI AY571984. BLASTn analysis against PlasmoDB revealed that the sequences from all isolates shared more than 70% similarities with the P. falciparum mdr1 gene located on chromosome 5. Furthermore, deduced amino acid sequences indicated an open reading frame of 4395 nucleotides encoding a protein with predicted molecular mass of approximated 165,000 Da. BLASTP analysis showed 70, 63, and 64% similarities with predicted proteins from P. falciparum (Accession No. AAA29646.1), P. chabaudi (Accession No. AAM82617.1) and P. yoelii MDR1 (Accession No. EAA22011), respectively. This analysis also revealed the presence of conserved nucleotide binding sites (NBS) of the ATP binding cassette (ABC) protein family in two halves of the molecule each of which also contained 12 predicted membrane-spanning domains (Fig. 1) . Multiple sequence alignments including MDR protein sequences from P. falciparum, P. chabaudi, and ABC transporters from Drosophila melanogaster (CG10226-PA) and human (NP 061337.1), further confirmed that the P. vivax sequences pertain to the ABC protein family (Fig. 1) . Moreover, using the last released version of the TIGR P. vivax genome project, a 307,346 bp contig containing the P. vivax mdr sequences was identified and compared to the homologous region of the P. falciparum genome using the ACT tool. The results demonstrated a large degree of synteny of this genome region between these two human malaria parasite species (not shown). Together these data strongly suggest that this P. vivax gene encodes a P-glycoprotein orthologue of pfmdr1 and accordingly we have termed it pvmdr1.
Chloroquine is still the primary chemotherapeutic drug for treatment of P. vivax but unfortunately resistance is emerging in several malaria regions of the world (Wellems and Plowe, 2001) . To determine whether an association exists between point mutations of the pvmdr1 gene and CQR, similarity and dendrogram analyses were performed using pvmdr1 sequences from isolates of different geographical regions and with different chloroquine response (Fig. 2) . Interestingly, these analyses revealed that sequences could be grouped according to their geographical origin and that within each geographical group resistant isolates branched independently; yet, there was no association of amino acid substitutions with CQR.
Knowledge about genetic diversity and population structure of P. vivax remains limited (Cui et al., 2003) . Studies on gene diversity and population structure will help in predicting and monitoring the effectiveness of intervention strategies such as the usefulness of therapeutic regimens, the dispersion of drug resistance, and the emergence of multidrug-resistant parasites. For example, a direct correlation of pvdhfr point mutations from four different allelic variants with pyrimethamine resistance and geographic distribution of P. vivax, has been reported (Imwong et al., 2001 ). In contrast, no association has been found between point mutations of the P. vivax homolog gene of the P. falciparum CRT and the chloroquine response of different P. vivax isolates, including some of the samples used in the present work (Nomura et al., 2001) . Similarly, our results failed to detect a correlation of pvmdr1 allele variants and CQR and are thus in agreement with results that have not linked polymorphism of the P. falciparum mdr1 gene with chloroquine resistance (Wellems et al., 1990) . The mechanism of CQR in P. vivax remains to be determined.
There is presently no consensus definition of drug resistance in P. vivax; yet, it is clear that chloroquine resistance and multiple drug resistance will spread. Genes related to pyrimethamine resistance, pvdhfr (Eldin de Pecoulas et al., 1998; Imwong et al., 2001) , chloroquine resistance, pvcg10 (Nomura et al., 2001 ) and multiple drug resistance, pvmdr1 (the present work) have been characterized in P. vivax. With the imminent release of the P. vivax genome (http://www. tigr.org/tdb/e2k1/pva1/), and annotations facilitated through ESTs gene discovery (Merino et al., 2003) , it is likely that in silico analysis will predict additional transporter and drug resistance genes as has been recently reported for P. falciparum (Mu et al., 2003) . Along with the development of new technologies for P. vivax such as the shortterm in vitro cultures to monitor drug-resistance (Chotivanich et al., 2004) it is hoped that monitoring and control strategies will help control worldwide spread of multiple drug resistant P. vivax parasites. Fig. 2 . Phylogenetic tree and geographic distribution of pvmdr1 allele variants. A phylogenetic tree based on sequence alignments of deduced amino acid sequences from putative PvMDR1 of all 10 isolates was generated using Molecular Evolutionary Genetics Analysis, MEGA, software version 2.1 (http://www.megasoftware.net/text/news.sht). This tree was adapted to display the geographical distribution of the samples. The neighborjoining model was used to construct the bootstrap consensus tree (1000 replicates used to estimate the standard error) with distance option of amino acids number of differences. Shaded areas represent the geographical origin of the different samples. 
